NEW YORK - Biotech firm GeneMe announced on Thursday a partnership with lyophilization services provider Biolyph to support the of scaling up GeneMe's rapid isothermal molecular point-of-care COVID-19 assay.
Financial and other terms of the deal were not disclosed.